Acumen Pharmaceuticals, Inc. (ABOS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $122.83M | -48.6% |
| 2024 | $238.99M | -22.9% |
| 2023 | $310.12M | +57.8% |
| 2022 | $196.59M | -14.6% |
| 2021 | $230.33M | +418.4% |
| 2020 | $44.43M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $122.83M | -48.6% |
| 2024 | $238.99M | -22.9% |
| 2023 | $310.12M | +57.8% |
| 2022 | $196.59M | -14.6% |
| 2021 | $230.33M | +418.4% |
| 2020 | $44.43M | — |